• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局灶性硬化性肾小球肾炎的长期预后。对250例病例的分析,特别关注肾小管间质变化。

Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes.

作者信息

Wehrmann M, Bohle A, Held H, Schumm G, Kendziorra H, Pressler H

机构信息

Institute of Pathology, University of Tübingen, FRG.

出版信息

Clin Nephrol. 1990 Mar;33(3):115-22.

PMID:2323110
Abstract

The following results were obtained in a long-term retrospective study including 250 patients with focal sclerosing glomerulonephritis: 1. The renal survival rate (RSR) was 90% at 5 years and 67% at 10 years, the average period of observation being 4.7 years. 2. Univariate analysis revealed that the following morphologic and clinical parameters are associated with an increased risk of terminal renal failure or death due to renal causes: a) Tubulointerstitial changes in the form of interstitial fibrosis, with or without acute renal failure; b) Advanced glomerular lesions; c) Advanced vascular alterations; d) Nephrotic syndrome present at the time of the biopsy; e) Elevated serum creatinine concentration at the time of the biopsy; f) Arterial hypertension at the time of the biopsy; g) Greater age at diagnosis; h) Male sex. 3. Multivariate survivorship analysis showed that tubulointerstitial changes and the presence of nephrotic syndrome at the time of biopsy are the only variables with significant independent predictive value for the outcome. Assessment of these factors thus allows the pathologist to make a relevant statement concerning the probable course and prognosis of the disease at the time of the diagnostic biopsy.

摘要

在一项纳入250例局灶性硬化性肾小球肾炎患者的长期回顾性研究中,获得了以下结果:1. 5年时肾脏存活率(RSR)为90%,10年时为67%,平均观察期为4.7年。2. 单因素分析显示,以下形态学和临床参数与终末期肾衰竭或肾脏原因导致的死亡风险增加相关:a)以间质纤维化为形式的肾小管间质改变,伴或不伴急性肾衰竭;b)重度肾小球病变;c)重度血管改变;d)活检时存在肾病综合征;e)活检时血清肌酐浓度升高;f)活检时动脉高血压;g)诊断时年龄较大;h)男性。3. 多因素生存分析表明,肾小管间质改变和活检时肾病综合征的存在是对结局具有显著独立预测价值的唯一变量。因此,对这些因素的评估使病理学家能够在诊断性活检时就疾病可能的病程和预后做出相关陈述。

相似文献

1
Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes.局灶性硬化性肾小球肾炎的长期预后。对250例病例的分析,特别关注肾小管间质变化。
Clin Nephrol. 1990 Mar;33(3):115-22.
2
Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes.慢性特发性膜性肾小球肾炎的长期预后。对334例病例的分析,特别关注肾小管间质变化。
Clin Nephrol. 1989 Feb;31(2):67-76.
3
Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.膜性肾病的临床和形态学预后因素:局灶节段性肾小球硬化的意义
Am J Kidney Dis. 2003 Jan;41(1):38-48. doi: 10.1053/ajkd.2003.50015.
4
Clinical and morphological predictors of renal outcome in adult patients with focal and segmental glomerulosclerosis (FSGS).成年局灶节段性肾小球硬化(FSGS)患者肾脏预后的临床和形态学预测指标
Clin Nephrol. 1996 Dec;46(6):362-8.
5
A follow up study of adult nephrotic syndrome in Nigerians: outcome and predictors of endstage renal failure.尼日利亚成人肾病综合征的随访研究:终末期肾衰竭的结局与预测因素
Afr J Med Med Sci. 1993 Jun;22(2):43-50.
6
The natural history of focal segmental glomerulosclerosis with and without mesangial hypercellularity in children.儿童伴和不伴系膜细胞增多的局灶节段性肾小球硬化的自然病程
Clin Nephrol. 1978 Feb;9(2):45-54.
7
Long-term outcome of adult patients with minimal urinary abnormalities and normal renal function.成年患者尿异常轻微且肾功能正常的长期预后。
Clin Nephrol. 1999 Jul;52(1):5-9.
8
The long-term prognosis of benign nephrosclerosis accompanied by focal glomerulosclerosis and renal cortical interstitial fibrosis, designated so-called decompensated benign nephrosclerosis by Fahr, Bohle and Ratscheck.良性肾硬化伴有局灶性肾小球硬化和肾皮质间质纤维化的长期预后,法尔、博勒和拉特谢克将其称为所谓的失代偿性良性肾硬化。
Pathol Res Pract. 1998;194(8):571-6. doi: 10.1016/S0344-0338(98)80047-2.
9
Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis.寡免疫性坏死性肾小球肾炎患者死亡和终末期肾病的临床病理预测因素
Am J Kidney Dis. 2003 Jan;41(1):29-37. doi: 10.1053/ajkd.2003.50013.
10
Contribution on the correlation between morphometric parameters gained from the renal cortex and renal function in IgA nephritis.关于IgA肾病中肾皮质形态学参数与肾功能之间相关性的研究
Lab Invest. 1988 Aug;59(2):239-44.

引用本文的文献

1
Population risk predictors of major adverse kidney events attributed to focal segmental glomerulosclerosis from the CURE-CKD registry.来自CURE-CKD注册研究的局灶节段性肾小球硬化所致主要不良肾脏事件的人群风险预测因素
BMC Nephrol. 2025 Jul 19;26(1):403. doi: 10.1186/s12882-025-04334-6.
2
Population Risk Predictors of Major Adverse Kidney Events in Patients with Focal Segmental Glomerulosclerosis from the CURE-CKD Registry.来自CURE-CKD注册研究的局灶节段性肾小球硬化患者主要不良肾脏事件的人群风险预测因素
Res Sq. 2025 May 6:rs.3.rs-5844460. doi: 10.21203/rs.3.rs-5844460/v1.
3
Proteinuria as an End Point in Clinical Trials of Focal Segmental Glomerulosclerosis.
蛋白尿作为局灶节段性肾小球硬化症临床试验的终点指标
Am J Kidney Dis. 2025 May;85(5):610-617. doi: 10.1053/j.ajkd.2024.08.011. Epub 2024 Oct 23.
4
Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort.德国慢性肾脏病队列中成人局灶节段性肾小球硬化症的长期预后
Clin Kidney J. 2024 Apr 27;17(7):sfae131. doi: 10.1093/ckj/sfae131. eCollection 2024 Jul.
5
Efficacy of extracorporeal plasma therapy for adult native kidney patients with Primary FSGS: a Systematic review.体外血浆治疗成人原发性局灶节段性肾小球硬化症患者的疗效:系统评价。
Ren Fail. 2023 Dec;45(1):2176694. doi: 10.1080/0886022X.2023.2176694.
6
Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease.局灶节段性肾小球硬化症和微小病变性肾病的潜在尿液蛋白质组生物标志物。
Int J Mol Sci. 2022 Oct 20;23(20):12607. doi: 10.3390/ijms232012607.
7
Vaccination against connective tissue growth factor attenuates the development of renal fibrosis.接种结缔组织生长因子可减轻肾纤维化的发展。
Sci Rep. 2022 Jun 29;12(1):10933. doi: 10.1038/s41598-022-15118-5.
8
Urinary Protein and Peptide Markers in Chronic Kidney Disease.慢性肾脏病的尿蛋白和肽标志物。
Int J Mol Sci. 2021 Nov 9;22(22):12123. doi: 10.3390/ijms222212123.
9
Sex and kidney ACE2 expression in primary focal segmental glomerulosclerosis: A NEPTUNE study.原发性局灶节段性肾小球硬化症中肾脏和性别的 ACE2 表达:NEPTUNE 研究。
PLoS One. 2021 Jun 7;16(6):e0252758. doi: 10.1371/journal.pone.0252758. eCollection 2021.
10
Cyclophosphamide as a Treatment for Focal Segmental Glomerular Sclerosis Recurrence in a Kidney Transplant Patient.环磷酰胺治疗肾移植患者局灶节段性肾小球硬化复发。
Am J Case Rep. 2021 Feb 4;22:e929097. doi: 10.12659/AJCR.929097.